Keywords: skyepharma, zileuton, partner, critical, thera, co-promotion, accord

SkyePharma's zileuton partner Critical Thera in co-promotion accord

Article | 26 March 2007

Print This

UK-based drug developer SkyePharma says that US firm Critical Therapeutics, with which it is developing the asthma drug zileuton CR, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in